Cancer Prevention and Screening Account for Most Cancer Deaths Averted Among Different Interventions Across the Cancer Control Continuum By Ogkologos - February 3, 2025 483 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a model-based study using population-level data Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Poherdy Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers FDA Approves Relacorilant with nab-Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer MOST POPULAR FDA Grants Accelerated Approval to Ponatinib with Chemotherapy for Newly Diagnosed... March 29, 2024 Holiday Coping and Enjoying December 17, 2021 Adding Atezolizumab to Cabozantinib Fails to Improve Clinical Outcomes and Increases... June 13, 2023 Treatment in Breast Cancer Patients Over 70 May Be Safely Reduced April 21, 2021 Load more HOT NEWS NICE doesn’t recommend ibrutinib drug for those with Waldenstrom’s macroglobulinaemia ΝΕΑ ΓΙΑ ΤΟΝ ΚΑΡΚΙΝΟ ΤΟΥ ΜΑΣΤΟΥ A new year of expanding research horizons ‘Levelling Up’: What should it mean for cancer?
